07 Dec, 2016 What’s Next For Risperdal? By Andrew Steinberg | Current Litigation & Lawsuit News,Dangerous Prescription Drug | 0 Comments Since healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals settled a Risperdal case in October, other plaintiffs in the Risperdal litigation hoped the settlement would set... Read More
